Neuroscience startup raises $53M Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Thu F 4 December, 2025

If reaching biopharma’s most influential decision-makers is a 2026 priority, this live Q&A will show you where Endpoints is headed — and how brands are turning that reach into impact. Join founder and CEO Arsalan Arif for an insider session built for marketing and communications professionals. Register now.

presented by Writ­ing the Next Chap­ter in CLL Care: Bridg­ing Gaps Through In­no­va­tion and In­sights

news FDA names Tracy Beth Høeg, who helped lead Covid shot investigation, as acting CDER chief Former FDA commissioners slam Prasad's plan for 'sweeping' vaccine changes Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron ARCH, Lilly Asia Ventures return to back US-China startup SciNeuro Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen

Dec 09 11:00am ET Strategic solutions for cost, time and quality challenges in drug development sponsored by Cambrex Dec 16 11:30am ET Ensure EU GMP Annex I compliance while maintaining sterile injectable manufacturing excellence & agility sponsored by Grand River Dec 17 12:00pm ET Genetic cohorting and therapeutic response in CKD: Real-world insights from RenasightIQ™ sponsored by Natera

The hematology sector heads into ASH under pressure, with data that could reshape R&D strategies and investment decisions across blood disorders. Join our expert analysis of the year’s most consequential readouts. Sign up today.

in case you missed it 1. FDA seeks to raise user fees for companies running Phase 1 trials outside the US 2. FDA says it won't release details of claimed Covid vaccine deaths in 'near term' 3. With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection 4. Pfizer-allied molecular glue startup collects $120M Series B 5. Excelsior Sciences raises $95M for small molecule drug discovery, manufacturing 6. Cosmo Pharmaceuticals’ shares rise after Phase 3 win in male pattern hair loss 7. Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner 8. Updated: Bristol Myers pushes back Cobenfy readout after trial site 'irregularities' 9. Updated: Pharvaris’ hereditary angioedema drug gets Phase 3 win 10. News Briefing Orion's €180M milestone payment; Iolyx partners dry eye candidate